NasdaqCM:PAYSDiversified Financial
Assessing Paysign (PAYS) Valuation After Record Q1 Results And Patient Affordability Shift
Paysign (PAYS) is back in focus after reporting record first quarter 2026 results, with revenue of US$28.04 million and net income of US$5.44 million, while its patient affordability business became the largest contributor.
See our latest analysis for Paysign.
The share price has been volatile around these earnings, slipping 2.94% on the day and 9.65% over the past week. However, the 90 day share price return of 65.78% and 1 year total shareholder return of 55.89% still point to strong recent...